Skip to Main Content

Paper Details

Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy.
Transplantation and Cellular Therapy
3
2022
MRD, Multiple Myeloma, NDMM, NGF, Patients, melphalan, multiple myeloma, patients

Datasets

Release 1.2